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ABSTRACT 
Context: The World Health Assembly Palliative Care Resolution in 2014 and the inclusion of palliative 
care within the Sustainable Development Goals raised optimism that palliative care would no longer 
be a peripheral aspect of global health. However, no funding, accountability measures or indicators 
for palliative care development accompanied these policy developments. This risks health actors 
continuing to prioritise the attainment of better known, target-driven aspects of healthcare.  
Objectives: To explore the attitudes of international palliative care experts regarding how the future 
development of palliative care can be accelerated. 
Methods: Sixteen international palliative care experts were interviewed for their epistemic 
expertise. Participants were interviewed face to face or via skype. Interviews were recorded, 
transcribed non-verbatim and analysed using a thematic approach (NVIVO). 
Results: Participants strongly supported the rollout of national palliative care policies around the 
world for two reasons: 1) to ensure palliative care attracts national funding streams and 2) to attract 
global funding for palliative care. The absence of a global indicator for palliative care development 
was considered a severe impediment to the inclusion of palliative care within global efforts towards 
Universal Health Care (UHC). Advocacy partnerships, using human rights approaches with economic 
‘frames’, were considered the most effective methods of influencing policymakers.  
Conclusions: Palliative care represents a value proposition which is not currently being maximised by 
advocacy. Advocates should consider palliative care developmentally, focussing upon ‘key asks’ for 
development and consider how palliative care can contribute to other international development 
priorities, in particular poverty reduction.    
 
Abstract word count: 247 (limit 250) 
Key words: ‘palliative care’ ‘public health’ ‘universal health coverage’ ‘sustainable development 
goals’ ‘advocacy’ 
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INTRODUCTION 
In 2014, the World Health Assembly (WHA) ratified a Palliative Care Resolution calling for national 
governments to integrate palliative care as an essential component within all levels of health 
systems.1 This is an ambitious aim, which seeks to deliver the WHO definition of palliative care. Our 
project adopts the WHO definition of palliative care as an approach that improves the quality of life 
of patients and their families, applicable to any life-limiting illness and appropriate from diagnosis.2  
The WHA Resolution situated palliative care as a ‘component of comprehensive care throughout the 
life course’, ending years of neglect from global policymakers. WHA Resolutions may be considered 
important political statements. However, they are not enforced by any global agency and are reliant 
upon member-state implementation. Moreover, no funding was made available for implementation 
and no targets were set within the new global health priorities, the Sustainable Development Goals 
(SDGs) for the attainment of the Resolution. This risks palliative care being overlooked by national 
policymakers as they may prioritise direction of limited funds towards the attainment of more 
established, measurable global health policy goals.3  
In the absence of palliative care and effective pain relief, patients are under-treated (through the 
absence of palliative care ) or over-treated as expensive, potentially distressing, curative treatments 
are continued beyond a time that they are likely to be effective.4 In both circumstances, people with 
serious illness may suffer extremely and unnecessarily with health spending poorly directed. To date, 
palliative care has predominantly developed in high-income countries, where funding for services 
has largely come from national health budgets and charitable sources.5 Most low and middle-income 
countries do not have national palliative care policies and access to services is extremely limited. The 
challenge of implementation of the Resolution is therefore significant as many healthcare systems 
around the world face significant challenges in the provision of other basic services, without ‘adding’ 
palliative care provision. Additional resources will therefore be required for the implementation of 
the WHA resolution.  
 
Many health systems in low and middle-income countries are funded through a combination of 
national-funding and external funding from bilateral international aid and global health agencies 
such as the World Bank.6 With national-resources extremely limited – and already allocated towards 
other health concerns – there appears to be a necessity for engagement from global funders. In a 
market-place of competing claims for resources, a key challenge for advocacy will therefore be to 
‘frame’ palliative care in an acceptable manner to global funding agencies.  
In global health research, it is known how funders prioritise ‘tractable’ issues (where a serious 
problem and solution are defined) and which are aligned with their organizational objectives. For 
example, the World Bank conceptualises health as a mechanism for economic growth and is 
therefore receptive to health interventions which promote human capital.7 However, such 
perspectives have not yet been incorporated in to palliative care research and advocacy. In recent 
years global advocacy has focussed upon the need for palliative care as a human rights issue.8,9 This 
is problematic, as funders like the World Bank are known to be resistant to rights-based claims. 
Moreover, ‘palliative care’ is a non-prescriptive approach, making ‘access to palliative care’, difficult 
to define and little is known regarding the effectiveness and feasibility of different models of 
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palliative care in all settings. 10 Lastly, the outcomes of palliative care intervention are so varied that 
there is no single indicator to measure development.  
New approaches to advocacy are therefore required which situate palliative care not as an issue in 
isolation, but as a key global health issue. Our qualitative study reports the views of international 
palliative care experts regarding the feasibility of implementing palliative care in all settings. Our 
study adds new perspectives regarding how problem of ‘lack of palliative care’ should be defined 
and how palliative care can contribute to broader global health goals.  
The aim of this study was to explore: 
 Expert views on how global palliative care advocacy efforts may be refined to 
ensure that palliative care makes gains within the global health priority of achieving 
Universal Health Care (UHC). 
METHODS 
Given the exploratory nature of this enquiry, a qualitative study design was used. In-depth, semi-
structured interviews were conducted to elicit rich data from 15 international palliative care experts 
and a patient-representative with experience of international palliative care research. This approach 
was justified, as neither the questions nor analysis required quantifiable data.11 Instead, the 
intention of interviews was largely to facilitate rich conversations.12  
Participants and recruitment 
We recruited a diverse study sample in terms of professional background and world region. Initially, 
a purposive sampling approach was used, contacting experts known by the authors to be active in 
palliative care internationally using email. Secondly, participants were recruited face-to-face at the 
European Association for Palliative Care (EAPC) international conference in Copenhagen, 2014, using 
a pragmatic approach based upon the recommendations of existing participants, with a purposive 
approach. All those approached agreed to take part and sixteen semi-structured interviews were 
conducted. The characteristics of the study population are presented in Table 1 including a public-
patient representative, who was included to guard against reporting purely professional views. 
Recruitment was ended when interview data were reinforcing emergent themes and no new topics 
were emerging. 
Table 1: Characteristics of study population (n=16)  
Data collection and analysis 
An interview guide was developed and piloted following a review of relevant literature and policy 
(Table 2). The interview guide aimed to explore attitudes towards a developmental approach to 
palliative care integration and aspects of a palliative care advocacy strategy. 
Table 2: Key areas for discussion within interviews  
Interviews were electronically recorded, transcribed non-verbatim and anonymised with transcripts 
(n=16) imported into 'NVivo 10.13 Themes were developed using qualitative content analysis and 
informed by a Global Social Policy (GSP) theoretical perspectiveError! Bookmark not defined. in a 
five stage process14 consisting of: 1) sensitisation to the data, 2) double-free coding, 3) theme 
development, 4) review of themes and 5) an iterative approach to writing.15 
Mind maps were used in order to draw out complexities and overlaps between codes16  and a coding 
framework was developed with core and sub-themes identified. 17 Coding and theme development 
was conducted individually by JC/CG with an ongoing process of constant comparison, to reduce 
potential researcher bias and increase internal validity.18 After this process, all data could be 
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associated with established themes. Direct quotations have been selected to illustrate the issues 
raised by participants and are generally indicative of many responses.  
Ethical Approval 
The study was granted ethical approval from the School of Health and Related Research (ScHARR) 
ethics committee at the University of Sheffield. A Participant Information Sheet was presented to 
participants prior to interviews. All participants provided oral consent and interviews were audio-
recorded. Interviews and the informed consent process were conducted by JC. 
RESULTS 
Three themes emerged from the data to inform global palliative care advocacy:  
1) Organization and funding of services;  
2) Global policies and leadership; and  
3) Re-Framing palliative care advocacy 
Organization and Funding of Services 
Participants were highly supportive of the WHO’s public health approach and the need for additional 
resources for palliative care development. Participants emphasised the need for countries to have 
National Strategies for implementation, but had diverging views as to whether Strategies and 
advocacy should aim at securing national-level funding streams for palliative care or funding from 
alternative sources: 
The funding for palliative care needs to come mainly from national governments. At least it 
depends, in some countries its healthcare insurance, in other countries it’s the government 
directly who finances healthcare and that’s the direction it needs to go in I feel. Pharmacist, 
Europe, (01) 
Participants acknowledged that worldwide, awareness of palliative care remains low and that health 
systems around the world face serious challenges in the delivery of healthcare. Yet, common views 
were expressed that the roll-out of palliative care is not only achievable through a reallocation of 
resources, but is itself a mechanism for cost-reduction and the ongoing sustainability of health 
systems.   
If there is a category of patients who are in pain, who are not treated for the pain now and 
need a lot of support almost continuously, healthcare systems or economies would save a lot 
of money if they treat the patients for their pain. And that can be either that a nurse can do 
something else, or you need less nurses or that a relative taking care of a person at home can 
go back to work or do other things. Pharmacist, Europe (P01) 
Lastly within this theme, many participants raised a key question about what a ‘minimum package’ 
of palliative care should be. Participants indicated that this was a key issue for palliative care 
advocacy and raised questions about the feasibility of rolling out holistic care and the relative 
importance, feasibility and acceptability of different aspects of ‘palliative care’.  
The Universal Health Coverage movement and what we are all aiming for, you know, there’s 
a global movement for UHC, so one of the things is how we can get palliative care as a 
component of the Universal Health Coverage, they will also… want to know what is the 
minimum package that Universal Health Coverage needs to cover. Physician, South America 
(P09) 
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In our research and advocacy, we’ve prioritized treatment of pain because it’s often the most 
pressing issue for patient and family. Activist, North America (P12)   
Global Policies and Leadership  
Many participants were satisfied with the global level leadership provided by the WHO and pointed 
to examples of ‘pioneers’ providing national-level leadership affecting positive change towards the 
further development of palliative care.  Despite this, other participants reported both a need for 
more ‘leadership’ within nations and from global actors. There was acknowledgement of the need 
for increased and improved leadership at all levels, with examples of emerging international 
‘leadership’ programs leading to positive change: 
It’s actually quite staggering what some of these people have done. Way beyond what a 
typical graduate in the UK, or the Unites States would do, these people are really advancing 
palliative care in their country, and they’re often doing it with great difficulty. Physician, 
North America (P13)  
Participants were united in their positivity regarding the future of palliative care in the wake of the 
WHA Resolution. However, a key concern was the absence of an enforcement mechanism for the 
Resolution and of the ongoing regulation of essential medicines by the International Narcotics 
Control Board (INCB). In this regard, an ongoing role for civil society actors was suggested, to 
continue lobbying, forge partnerships and to use different approaches to engage policymakers:  
Governments are actually a bit peeved when you come at them with human rights, it’s a 
confrontational discussion, but that’s one of the reasons why Human Rights Watch and 
World Hospice Palliative Care Alliance and International Association of Hospice and Palliative 
Care [IAHPC], have such a good partnership, because Human Rights confronts, and we 
[IAHPC] say ‘how can we help you improve?’ Physician, Africa (P07) 
As well as calls for increased leadership and critique of global level policies, participants expressed 
frustration that palliative care commonly continues to exist on the outskirts of the medical 
mainstream. In this regard, participants called for new sources of financing to move away from 
short-term charitable funding, towards a sustainable global model of palliative care development:  
You can’t really have an impact if you’re going to be outside the system and you’re going to 
just use charitable dollars to take care of a few patients, which somebody called, ‘deluxe 
dying for the few’. Physician, North America (P03) 
It’s time for governments, the UN and the World Bank to step up to the plate and stop letting 
us carry the water for them. Activist, North America (P02) 
Lastly, several participants strongly expressed the need for palliative care development to be 
‘measurable’. Thus, the lack of an indicator for palliative care within the SDGs was considered a 
serious blow for advocates at national and global levels.  
Once we have an indicator, we can then go to our Ministry and say ‘you need to be held 
accountable to this indicator’, so you need this indicator to be part of your Country 
Operational Plan, then when we go to USAID, we can say ‘this is part of the Kenyan 
Operational Plan, this thing is in the plan, please fund it’. Activist, Africa (P16) 
1) Re-Framing Palliative Care Advocacy 
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Participants were united in the view that in order to further the global development of palliative 
care, focussed advocacy was required, at micro (local), meso (national) and macro (global) levels of 
global governance. At national and local levels, participants emphasised the need for advocacy 
approaches that focussed upon raising awareness through story-telling, experiential learning and 
engagement with local communities:  
I think the experiential effect of knowing somebody who has received palliative care, 
reverberates around the community, and that, changes perceptions, it raises expectation. I 
was looking after a Minister’s mother, one of the Ministers in the government, and we 
provided palliative care to his mother and he said, ‘now, if you can do this, why can’t our 
hospitals do this? Because they had been in their own hospitals and private hospitals, ‘you’re 
providing a free service and you’re doing what others can’t do’. I said, ‘that’s a challenge to 
you, you’re in a position of power…you make the change’. Physician, Asia (P05) 
 
A key perceived barrier at the global level however, related to the difficulty of ‘getting a seat at the 
table’ in order to influence policymakers. When asked which organizations should be the targets for 
advocacy one participant reported: 
The big UN agencies, of course, WHO, USAID, UNICEF, all of these we are acting with, at 
present, we actually have a side-event at the World Health Assembly in two weeks’ time 
specifically for paediatric palliative care, so that’s where we’re really going to give the 
message around paediatric palliative care, but I think you know, also… global level funders, 
like Global Fund, USAID, the Gates Foundation, it’s just finding a way to get in there. I’m sure 
if we could get in there we could make the argument, but it’s not that easy… Nurse, Africa 
(P06) 
A proposed method of overcoming this was to forge partnerships. The importance of the need for a 
diverse range of arguments for the development of palliative care was also put forward alongside a 
change of language:  
When you look globally, there’s a lot of discussions around end of life care… [but] anything to 
do with death is not good, and whilst palliative care people are very open to talk about death 
and dying, the general population are not…. I think that’s where we do need better, things 
like selling the product, marketing. Physician, Asia (P05) 
When asked how arguments for palliative care could be framed within existing global funding 
priorities, participants reported that in certain circumstances where patients do not access palliative 
care and pay for their healthcare, that expensive (and potentially futile) treatments lead to financial 
difficulty for families. Palliative care could contribute to both poverty reduction and poverty 
avoidance and was therefore relevant to broader priorities of international development: 
In India I’ve seen it, where patients are referred to hospitals and for intensive treatment and 
families go into debt, and they become ‘debt-slaves’ that’s what some of my colleagues call 
it. Activist, North America (P02) 
Some of the [patients’] symptoms once they are controlled… once pain is managed, some of 
these people are able to go back to productive work, so it’s helping them make sure that 
these people stay as healthy, as pain free and as symptom free as possible, so that they can 
continue with their every day job. Activist, Africa (P16) 
Participants used rights-based language during discussions and support was expressed for access to 
palliative care to be a human right. However, there was also acknowledgement that existing human 
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rights laws were not drafted to purposefully include palliative care. Participants suggested palliative 
care was an element of two existing human rights: the right to freedom from torture and the right to 
health: 
You have to construct that right. You know, the right to the highest attainable level of 
physical and mental health and clearly, palliative care falls within that right. Activist, North 
America (P12) 
All participants presented access to pain and palliative care services as a moral imperative. Indeed, 
participants took a highly principled stance in all interviews arguing that it was incumbent upon 
richer nations to assist poorer nations in the provision of palliative care:  
Under the principle of mutual and shared responsibility, which is a principle of international 
law, the more developed countries with money would finance, with technical assistance or 
whatever, whatever needs in the lower resource countries that they have, to develop their 
workforce and to develop their medical industries or whatever they need. Not as charity, but 
as mutual and shared responsibility.  Activist, North America, (P02) 
Some participants suggested that for the purposes of advocacy, gains could be made by focussing 
upon the suffering which children endure in the absence of palliative care due to the emotional 
impact of such images. However, it was also suggested that advocacy should focus upon positive 
stories as opposed to an emphasis on human suffering:   
If you look at the palliative care it has evolved showing lots of graphic images and people in 
pain and screaming and that is absolutely not good, it’s counter-productive, and we don’t 
want to show, to even increase vulnerability for people who are already vulnerable... I think 
sometimes we have used patients and used the circumstances to meet our own advocacy 
demands, but without any direct benefit to the people we have used, so I’m always very 
careful when we are using patients, if there is no direct benefit to that patient. Activist, Africa 
(16) 
DISCUSSION 
This global qualitative study provides insight in to the challenges and opportunities for the global 
development of palliative care. The three themes reported, combine to demonstrate the inter-
dependence of national and global health policies. National health policies are formulated within 
context of local need and a drive to attract funding, by directing policies towards the attainment of 
the SDGs. Yet, nationally-devised policies can also lead to engagement from global health funders, 
who operate within the obligations of the Paris Declaration on Aid Effectiveness to direct funding 
towards nationally-devised priorities.19  
Within this context, participants stressed that roll-out of palliative care was feasible in all income 
settings. A key reason for this is that, whilst some health systems will require new sources of finance 
for palliative care, in others, health spending is currently poorly directed. Indeed, in all resource 
contexts, participants reported that in the absence of palliative care, participants reported extensive 
‘overtreatment’ of serious illnesses at great financial cost. Even where palliative care services are 
available, patients and health professionals remain willing to continue (or commence) expensive 
curative treatments beyond a time they may be expected to be effective. This leads to unnecessary 
physical suffering for patients and, adverse economic consequences for households and health 
systems.20  
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Where services are available, it is an avoidable tragedy that palliative care is not commenced in 
favour of ongoing active treatments. Where access to services is low, development of palliative care 
– alongside curative services with appropriate referral pathways, represents the most cost-effective 
approach to high quality health delivery. Therefore, in some contexts advocacy should focus upon a 
reallocation of resources, whilst in low and middle-income settings, the emphasis may be upon 
securing new sources of finance for clinician training and service development. Yet, participants 
stressed that in all settings, there is still work for advocates to do in convincing a dubious public that 
palliative care can be viewed as a desirable treatment option.   
In Theme 1, participants identified the establishment of national palliative care policies as a 
developmental priority and an essential element of securing sustainable funding for palliative care 
services in two ways. In countries with the resources to do so, national governments must be 
lobbied to provide the funding for service developments.21 However, many health systems around 
the world are reliant upon Overseas Development Assistance (ODA) in order to continue to function. 
It is therefore essential that advocates and leaders push for palliative care to be included within 
National Health Strategies: for the dual purpose of attracting either national or global level 
funding.22  
Theme 2 reveals optimism from some participants regarding global situation regarding: the ongoing 
leadership provided by the WHO and the International Association of Hospice and Palliative Care 
(IAHPC) amongst others and global policies such as the WHA Resolution. Yet, this study also 
identified a leadership gap in terms of how palliative care activists are engaging with global funding 
agencies such as the World Bank. This risks target-driven ‘global health priorities’ crystallised within 
the SDGs receiving the majority of global funding at the expense of palliative care development.23  In 
the absence of an indicator for progress towards the WHA Resolution, civil society organizations 
retain a key role in holding governments that ratified the Resolution to their obligations. However, 
as funders increasingly operate ‘results-based financing’ approaches, it is essential that researchers 
work towards developing a consensus regarding what a palliative care indicator may look like. 24  
The recent Lancet Commission on Palliative Care and Pain Study Group report (2017) offers a timely 
response to such calls. The report moves beyond a focus upon pain to include other problems and 
symptoms, (e.g. breathlessness) through their articulation of a Serious Health-related Suffering (SHS) 
measure.25 The report also offers guidance on just what an ‘essential package’ of palliative care looks 
like. Crucially, however, the Commission stopped short of quantifying SHS into a measurable 
indicator, which limits the usefulness of the report for the purposes of advocacy. Indicators relevant 
to palliative care do exist, for example, Opioid Consumption per capita and cancer mortality. 
However, these indicators do not provide a measurable indicator about either access to palliative 
care for all life-limiting illnesses, or quality of services.  
Lastly, Theme 3 considers how activists should respond to this challenge by considering participants’ 
views regarding current and future palliative care advocacy strategy. In recent years much global 
palliative care advocacy has centred on the notion that access to palliative care is a ‘human right’.26 
In spite of general support amongst participants for this notion, there was also scepticism regarding 
the utility of rights-based approaches to advocacy. Some participants acknowledged that the ‘right 
to palliative care’ was something which has had to be ‘constructed’ within existing human rights 
legislation whilst others questioned the relevance of human-rights arguments to all world regions.27  
Advocates should therefore adopting new approaches. Moving forwards, some participants 
encouraged learning lessons from other related advocacy campaigns regarding of how the problem 
of ‘lack of access to palliative care’ is defined.28 This may mean advocates separating ‘palliative care’ 
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into its constituent elements by focussing upon the problems caused by the absence of different 
elements of palliative care, how these problems may be addressed and the benefits which may 
accrue from doing so. Indeed the aggregated measure of SHS is at odds with the preference of some 
participants to think developmentally and prioritise issues based on their importance and 
‘solvability’. Whilst opioid medications remain heavily regulated,29 access to pain treatment is not 
only the most pressing problem around the world, but the most tractable problem for presentation 
to policymakers. Advocates are able to clearly state the severity of problems faced by people due to 
lack of access to pain treatment for palliative care and other aspects of health (e.g. post-surgical 
care) and offer clear solutions such as appropriate regulations and prescribing. The benefits of 
effective pain management extend to promoting both human and social capital, arguments to which 
national policymakers and global funding agencies are likely to be responsive.30Poverty reduction 
and poverty avoidance are two key aims of international development.31 Data from our study as well 
as emerging research suggests palliative care may be able to contribute to both of these goals.32 
Families around the world are known to experience severe financial hardship related to the onset of 
a serious illness.33 Reduced costs benefit both health systems and poor families who pay for 
healthcare, whilst reduced caring burden and effective symptom management promote both human 
and social capital, freeing carers and patients to pursue economic gain and maintain usual functions. 
With the predominant care burden in many world settings falling upon women and children, a 
reduced caring role may promote school attendance and reduce inequalities. What is more, global 
funders such as the World Bank tend to be more amenable to health issues that promote ‘human 
capital’ as opposed to human rights and tend to fund projects with measurable outcomes.Error! 
Bookmark not defined. This raises the need for an indicator for palliative care development and 
reinforces that new approaches to advocacy are required in order to attract global-level funding. 
Such advocacy approaches must be supported by the research community to provide an evidence-
base for economic claims.  
Advocates may feel uneasy about conceptualising the value of palliative care economically. 
However, through the formation of partnerships and advocacy coalitions, diverse but mutually 
reinforcing arguments may be presented to policymakers.34 Participants reported for example, how 
partnerships formed between different, but complementary organizations such as the WHPCA and 
Human Rights Watch were effective in promoting positive change in terms of national drug 
regulations. Further partnerships should be forged with lobbies outside of palliative care for mutual 
benefit. Combining moral necessity with an economic imperative may be a fruitful way to engage 
health policymakers at all levels of health governance.35 
The present study had some limitations. First, data were collected at a single time-point in 2014 only. 
Second, data analysis was conducted by two European researchers meaning that there may be some 
implicit Eurocentric bias in our analysis in spite of ongoing reflection by JC/CG on such issues. For 
feasibility reasons, we were unable to collect further data to reflect changing views within the ever-
changing global health landscape and were not able to return transcripts to study participants for 
verification.  Our results should therefore be read only in the context presented.  
In conclusion, palliative care appears to offer a value proposition which is not currently being 
maximised by research and advocacy. Advocates should consider their promotion of palliative care 
developmentally, focussing upon ‘key asks’ using different ‘frames’ to resonate with different policy 
actors.  
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Table 1: Characteristics of study population (n=16)  
Study 
ID 
Region  Primary training / 
background 
Illustrative international role(s) and expertise  
01  Europe  Pharmacist  Senior pharmacist for International Organization  
02  N. America  Activist  Advocacy Officer for International Palliative Care 
Association  
03  N. America  Physician  Consultancy for International Palliative Care 
Associations  
04  Asia  Physician  President of National Association of Palliative Care, 
International palliative care education coordinator  
05  Asia  Physician  Medical Director of National Hospice,  Consultant for 
International Palliative Care Associations  
06  Africa  Paediatric Nurse  Chief Executive of an International Children’s 
Palliative Care Association  
07  Africa  Physician  CEO of national Hospice Palliative Care Association, 
Chair of International Palliative Care Association, 
Technical advisor to International Organization, 
Director of global palliative care media outlet  
08  Europe  Project Manager  Project Manager of philanthropy organization 
funding European palliative care leadership training  
09  S. America  Physician  Executive Director of International Hospice 
Association  
10  Europe  Private Physician  EAPC Task Force Member of Regional Palliative Care 
Association, International Researcher, 
Pharmaceutical Consultancy  
11  Europe  Patient-Public 
Representative 
(PPI)  
PPI Representation on international palliative care 
study 
12  N. America  Human Rights 
Activist  
Associate Director of Health and Human Rights 
Organization  
13  N. America  Physician  Board Member International Palliative Care 
Association  
14  Australasia  Physician, Lawyer  International Human Rights Law,  International 
palliative care capacity building consultant  
15  S. America  Physician  President of Regional Palliative Care Association  
16  Africa  Activist  Co-founder of Regional Palliative Care Association, 
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services across Africa, Lobbyist and Advocacy Officer 
for International Philanthropy organization 
 
 
 
Table 2: Key areas for discussion within interviews  
 How to conceptualise the global need for palliative care. 
 Examples from around the world where palliative care is working well and who benefits 
from this (and how).  
 Key organizations/individuals/partners as targets for palliative care advocacy. 
 Key arguments being made for palliative care at a global level (and who is making them). 
 If present, location of palliative care within current global health priorities.  
 Key objectives for global palliative care advocacy. 
 Identification of key realistic changes that palliative care should aim for. 
 Potential key partners for the palliative care lobby that do not work in palliative care 
currently. 
 Potential barriers/arguments against the further roll-out of palliative care.  
 
 
 
 
 
 
 
 
 
 
